Similar in vitro ATM-AVI activity was also observed irrespective of region, in which ≥99.7% Enterobacterales isolates from these infection sources were inhibited by ATM-AVI at ≤8 μg/mL (MIC90 of 0.12–0.25 μg/mL) in AfME, APAC, Europe, LATAM, and North America. Here, ATM is linked to infection.